TheEdgeResearch
Home / Stocks / LFWD

Lifeward Ltd. (LFWD)

NASDAQ Healthcare Medical - Devices
$7.74 ▲ +2.31%
Market Cap
$12.5M
Sector
Healthcare
Industry
Medical - Devices
Beta
0.38
52-Wk Range
4.14-10.56
CEO
William Mark Grant
Country
IL
Currency
USD

Lifeward Ltd. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Yokneam Illit, MA, IL. The stock last traded at $7.74, up 2.31% on the session, giving a market capitalisation of $12.5M. On trailing twelve-month figures it carries a trailing P/E of -0.39, a net margin of -123.7%. Its beta of 0.38 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.39
Price / Sales
0.60
Price / Book
1.98
EV / EBITDA
-0.58
Gross margin
36.6%
Operating margin
-120.3%
Net margin
-123.7%
Return on equity
Debt / equity
1.40
Current ratio
2.40
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
81
IPO date
2014-09-12
Headquarters
Yokneam Illit, MA, IL
About Lifeward Ltd.

Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.

Comparable companies

Lifeward Ltd. is most often compared with the following Healthcare names:

DHAIIINNINABLYRAPTHLRNAZSBFMSINTTNONXAIR
More research on LFWD
LFWD technical analysis LFWD TheEdge Score Compare against peers
Open full interactive analysis & DCF →